ArticleCureus2026
Progression of Atrioventricular Conduction Disorder Induced by Radiofrequency Ablation for Hepatocellular Carcinoma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiofrequency ablation (RFA) is generally considered a safe treatment for hepatocellular carcinoma. Although cardiovascular complications have been occasionally reported, they are primarily attributed to sedatives and analgesics or the vasovagal reflex. However, a unique case is presented where RFA itself was suspected of inducing a progressive atrioventricular disorder. An 80-year-old male underwent RFA for hepatocellular carcinoma. His electrocardiogram showed a first-degree atrioventricular block on admission. Prior to ablation, fentanyl and propofol were administered. Severe bradycardia developed immediately after initiation of ablation. RFA and propofol infusion were terminated, leading to prompt heart rate recovery. After approximately five minutes, ablation was resumed without propofol, but severe bradycardia recurred. The electrocardiogram during RFA revealed a complete atrioventricular block. Therefore, the procedure was terminated. A 12-lead electrocardiogram performed after the aborted procedure revealed progression to a second-degree AV block (Mobitz type II) requiring pacemaker implantation. The exact mechanism of this effect remains unclear, though progression of the atrioventricular conduction disorder was considered to be induced by RFA. Careful intraoperative patient management is crucial during RFA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.